These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
504 related articles for article (PubMed ID: 10421273)
1. The International Neuroblastoma Pathology Classification (the Shimada system). Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273 [TBL] [Abstract][Full Text] [Related]
2. [Peripheral neuroblastic tumors in childhood]. Bernhardt M; Vokuhl C Pathologie (Heidelb); 2023 Nov; 44(6):366-372. PubMed ID: 37819531 [TBL] [Abstract][Full Text] [Related]
3. High Oct4 expression: implications in the pathogenesis of neuroblastic tumours. Monferrer E; Burgos-Panadero R; Blanquer-Maceiras M; Cañete A; Navarro S; Noguera R BMC Cancer; 2019 Jan; 19(1):1. PubMed ID: 30606139 [TBL] [Abstract][Full Text] [Related]
4. A head-to-head comparison of computed tomography- and magnetic resonance imaging-based radiomics in assessing pediatric peripheral neuroblastic tumor cell behavior. Wang H; Chen X; He L; Ding H; Xie M; Cai J Abdom Radiol (NY); 2024 Aug; 49(8):2942-2952. PubMed ID: 38900321 [TBL] [Abstract][Full Text] [Related]
5. Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations. Nezami BG; Modak S; Cardenas FI; Sarungbam J; Sirintrapun SJ; Gopalan A; Chen Y; Al-Ahmadie H; Fine SW; Reuter VE; Tickoo SK Pediatr Blood Cancer; 2023 Aug; 70(8):e30434. PubMed ID: 37243318 [TBL] [Abstract][Full Text] [Related]
6. Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements. Yu Y; Zhang M; Yao X; Guan X; Jia C; Chu P; Zhang R; Yang Y; Jin Y; Wang H; Ni X; He L; Guo Y J Pathol Clin Res; 2023 Nov; 9(6):475-487. PubMed ID: 37608330 [TBL] [Abstract][Full Text] [Related]
7. Nonspecific Gastrointestinal Symptoms as the First Sign of Ganglioneuroblastoma Intermixed-Case Report and Literature Review. Lipiński Ł; Lipińska J; Kowalczuk M; Kopeć I; Woźniak MM; Mitek-Palusińska J; Mitura-Lesiuk M J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37763032 [TBL] [Abstract][Full Text] [Related]
8. Computer-assisted resection of multifocal primary neuroblastic tumors: A case report. Xiu W; Wu X; Hao X; Dong Q Asian J Surg; 2023 Dec; 46(12):6103-6104. PubMed ID: 37775384 [No Abstract] [Full Text] [Related]
9. Epidemiological and clinical characteristics of children with peripheral neuroblastic tumors: a study on a Moroccan population. Anissi Eddaibouni A; Bennani Guebessi N; Cherkaoui S; Karkouri M; Khoubila N; Maataoui-Belabbes H J Cancer Res Clin Oncol; 2023 Dec; 149(20):18023-18027. PubMed ID: 37979055 [TBL] [Abstract][Full Text] [Related]
10. Maturation of metastases in peripheral neuroblastic tumors (neuroblastoma) of children. Sarnat HB; Chan ES; Ng D; Yu W J Neuropathol Exp Neurol; 2023 Sep; 82(10):853-864. PubMed ID: 37682248 [TBL] [Abstract][Full Text] [Related]
11. Correlations between contrast-enhanced CT-measured extracellular volume fraction, histopathological features, and MYCN amplification status in abdominal neuroblastoma: a retrospective study. Wang H; Ding H; Xie M; Zhang L; Li T; Qin J; Chen X; He L Abdom Radiol (NY); 2023 Nov; 48(11):3441-3448. PubMed ID: 37452211 [TBL] [Abstract][Full Text] [Related]
12. The Evolution of Risk Classification for Neuroblastoma. Sokol E; Desai AV Children (Basel); 2019 Feb; 6(2):. PubMed ID: 30754710 [TBL] [Abstract][Full Text] [Related]
14. Consensus and agreements on the classification of fibrotic diseases. Tsai CF; Wang PH; Chen CC; Chen SC QJM; 2023 Oct; 116(10):882. PubMed ID: 37286378 [No Abstract] [Full Text] [Related]
15. Response to: Consensus and agreements on the classification of fibrotic diseases. Massen GM; Stewart I; Quint JK; QJM; 2023 Oct; 116(10):883. PubMed ID: 37286374 [No Abstract] [Full Text] [Related]
16. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303 [TBL] [Abstract][Full Text] [Related]
17. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. Cohn SL; Pearson AD; London WB; Monclair T; Ambros PF; Brodeur GM; Faldum A; Hero B; Iehara T; Machin D; Mosseri V; Simon T; Garaventa A; Castel V; Matthay KK; J Clin Oncol; 2009 Jan; 27(2):289-97. PubMed ID: 19047291 [TBL] [Abstract][Full Text] [Related]
18. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. Shimada H; Chatten J; Newton WA; Sachs N; Hamoudi AB; Chiba T; Marsden HB; Misugi K J Natl Cancer Inst; 1984 Aug; 73(2):405-16. PubMed ID: 6589432 [TBL] [Abstract][Full Text] [Related]
19. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099 [TBL] [Abstract][Full Text] [Related]
20. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Brodeur GM; Pritchard J; Berthold F; Carlsen NL; Castel V; Castelberry RP; De Bernardi B; Evans AE; Favrot M; Hedborg F J Clin Oncol; 1993 Aug; 11(8):1466-77. PubMed ID: 8336186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]